BioCentury
ARTICLE | Product Development

Back to School 2020: The imperative of COVID-19 — biopharma’s once-in-a-generation chance for change 

BioCentury calls on industry to convert its COVID response to a new era of efficient drug development and address the urgent healthcare chasms exposed by the crisis

September 7, 2020 11:02 PM GMT

Access This Article